Biofrontera (BFRI) Stock Statistics & Valuation Metrics

Biofrontera has a market cap or net worth of $8.95M. The enterprise value is $4.41M.

Biofrontera has 10,668,442 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biofrontera’s return on equity (ROE) is -4.01 and return on invested capital (ROIC) is -162.13%.

The current PE Ratio of Biofrontera is ―. Biofrontera’s PEG ratio is ―.

In the last 12 months, Biofrontera had revenue of 37.30M and earned -17.76M in profits. Earnings per share was -3.22.

In the last 12 months, operating cash flow was -9.39M and capital expenditures 45.00K, giving a free cash flow of -9.34M billion.

Biofrontera pays an annual dividend of ―, resulting in a dividend yield of ―

Biofrontera upcoming earnings date is Nov 30, 2025, Before Open (Confirmed).

Biofrontera as a current ratio of 1.72, with Debt / Equity ratio of -107.20%

In the past 12 months, Biofrontera has paid 22.00K in taxes.

Biofrontera EV to EBITDA ratio is -0.35, with an EV/FCF ratio of -0.49.

Biofrontera has $7.24M in cash and marketable securities with $5.00M in debt, giving a net cash position of -$2.23M billion.

Gross margin is 61.66%, with operating margin of -46.14%, and net profit margin of -47.61%.

The average price target for Biofrontera is $6.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy